US 12,364,694 B2
Organic compounds
Peng Li, New Milford, NJ (US); Qiang Zhang, Plainsboro, NJ (US); and Robert Davis, San Diego, CA (US)
Assigned to INTRA-CELLULAR THERAPIES, INC., Bedminster, NJ (US)
Appl. No. 17/040,892
Filed by INTRA-CELLULAR THERAPIES, INC., New York, NY (US)
PCT Filed Mar. 21, 2019, PCT No. PCT/US2019/023350
§ 371(c)(1), (2) Date Sep. 23, 2020,
PCT Pub. No. WO2019/183341, PCT Pub. Date Sep. 26, 2019.
Claims priority of provisional application 62/647,488, filed on Mar. 23, 2018.
Prior Publication US 2021/0009592 A1, Jan. 14, 2021
Int. Cl. A61K 31/4985 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); C07B 59/00 (2006.01); C07D 471/16 (2006.01)
CPC A61K 31/4985 (2013.01) [A61K 9/0019 (2013.01); A61K 45/06 (2013.01); C07B 59/002 (2013.01); C07D 471/16 (2013.01); C07B 2200/05 (2013.01)] 10 Claims
 
1. A compound of the formula:

OG Complex Work Unit Chemistry
in free or pharmaceutically acceptable salt form.